Categories: BioTechBodyDrugPersonalPlatformRecruitingTechnology
Attivare Therapeutics is a pre-clinical biotechnology company developing personalized cancer immunotherapy. ATTImmune delivers intratumoral immune agonists via a biomaterial scaffold; ATT-AI uses single-cell transcriptomics to select patient-specific drug combinations. Programs in AML, solid tumors, and infectious disease.
Investors 3
Mentions in press and media 1
| Date | Title | Description |
| 15.12.2025 | Attivare Therapeutics Receives $6.6M Grant | Attivare Therapeutics, a Natick, MA-based company treating tumors with low immunogenicity, received $6.6M in grant from Gates Foundation.
The company intends to allocate the amount for the advancement of a new long-lasting malaria vaccine, ... |
Reviews 0
